Cure at BIO International Convention June 5th-8th Boston, MA |
|
| Cure Studio On The Road: Cure Studios will be looking for people to stop by Booth #2242 between 8:00 AM-5:00 PM for coffee, happy hour, giveaways and share their take on the future of healthcare, the impact of AI and what ails them. |
|
During today's Bio 2023 Super Session, Seema Kumar, CEO, will announce the launch of CureXChange for innovative ideas at the intersection of disciplines and sectors to receive annual support from the program, which Cure is funding up to $1 million. The CureXChange will seek submissions of ideas focusing on using AI to solve critical healthcare challenges to cure what ails us. Winning teams will receive seed money, a one-year residency at the Cure innovation campus in New York City, access to the Cure network and ecosystem, mentorship, office hours, and resources, the value of which is $1M. |
|
| Date: Monday June 5 Time: 2:15-3:15 p.m. Location: Room 253 A, B, C, Boston Convention Center SuperSession Panel: Seema Kumar, Rick Bright, Daniel Kraft, Maria Luisa Pineda, Greg Petsko
Event details: Are you experiencing AI vertigo? The dizzying array of things AI can seemingly do--good, great, and worrisome—has the world of healthcare both excited and overwhelmed. Join Cure and expert speakers for a BIO super session that will explain how we can optimally leverage the breathtaking advances of AI and other advanced technologies. Can ChaptGPT go beyond the writing of school essays and emails to take on truly tough challenges in healthcare - like predicting Alzheimer’s, providing early warning systems for pandemics, and curing cancer?
We will start with futurist Daniel Kraft, MD taking us on a whirlwind tour of current and future health technologies. These include the creation of a “digital twin” - a physiological computer profile of “you”—that can use advanced testing and monitoring to predict your healthcare future, and hopefully to mitigate or prevent disease. A panel of experts will then showcase “here and now” examples of how AI is already being used to make sense of big data to speed up drug discovery and reduce costs; integrating new technologies like cell and gene therapies; advancing scanning technologies; and other new tech to better detect, diagnose, and treat cancer, Alzheimer’s disease, cardiovascular disease, and much more. Join us for this glimpse into the future and the announcement of a new initiative to answer questions on how to use AI For Good. |
|
|
|
| Rick Bright, PhD Former Chief Executive Office Pandemic Prevention Institute (PPI) at The Rockerfeller Foundation |
|
| Maria Pineda co-founder and CEO Envisagenics, Inc |
|
| Gregory Petsko Professor of Neurology Ann Romney Center for Neurologic Diseases Harvard Medical School and Brigham & Women’s Hospital |
|
| Daniel Kraft, MD Founder and Chair Nextmed Health |
|
| David Duncan Science Writer and Best-Selling Author |
|
| Date: Tuesday, June 6, 2023 Time: 8:15 a.m. Location: Main Stage, Boston Convention Center
Announcement details: Well established as the Biotechnology Institute's "flagship" program, the BioGENEius Challenge Series provides high school age students with expanded opportunity to compete and be recognized for outstanding research in biotechnology. Drawn from state and regional science competitions across the more than thirty State and our International partners, top finalists representing the upper 5% of applicants showcase their research at the BIO International Convention to some 16,000 attendees and a panel of judges comprised of industry and academic subject matter experts. The following awards are considered based upon the subject matter and excellence of the finalists' projects:
- The Global Healthcare Challenge in medical biotechnology
- The Global Sustainability Challenge in agricultural biotechnology
- The Global Environment Challenge in industrial and environmental biotechnology
|
|
| Date: Tuesday, June 6, 2023 Time: 6:00 p.m. – 7:30 p.m. Location: Boston Marriott Copley Place, 110 Huntington Ave. Boston, MA 02116 Women In BIO Panel: Aoife, Brennan, Seema Kumar, Geralyn Ritter, Nancy Simonian Event details: We are thrilled to be hosting WIB's Signature event during the BIO Convention. This will be an evening of community, networking, and a discussion you will not want to miss! WIB President Azurii Collier will provide the welcome remarks and introduce our esteemed panel. Women are a driving force behind every component of the biotechnology industry and ecosystem. However, very often, the story of their impact on the breakthrough is not highlighted. We want to elevate the voice of women in the industry and promote their specific impact in driving innovative change. Join us for a fireside chat with industry executives with a vast reach across numerous sectors in the life sciences. We will learn about their journey, decisions, and inflection points along the way as they create impact. These stories will undoubtedly inspire others to create a similar impact. |
|
| Geralyn Ritter Executive Vice President, External Affairs and ESG at Organon |
|
| Nancy Simonian MD, President and Chief Executive Officer of Syros Pharmaceuticals |
|
| Dear BIO Attendee,
As an innovation leader in healthcare, Cure® has a bold vision: to advance healthcare and Cure. Period. That’s why we have a period after our logo. We can’t do this alone. No single individual or organization can. That’s why we are focused on building an ecosystem of innovators across disciplines and sectors who will collaborate to solve critical healthcare challenges leveraging the latest science and technology, drive health equity and engender trust, and shape the future of healthcare by bringing together the community and society overall.
Our 300,000-square-foot innovation campus was purpose-built to encourage cross-disciplinary collaboration and the free exchange of ideas. Our state-of-the-art laboratories, medical device incubator, collaboration residency and dry lab office spaces enable cross-sector research. Today Cure houses 21 companies and a soon to be launched Cure innovation labs with a Lab of the Future and includes for-profit and non-profit organizations focused on medical technology, healthcare services, therapeutics, and healthcare investment. With an education center and event space to engage the community, Cure also serves as a hub for networking and professional development through a series of events, educational lectures, access to world-renowned subject matter experts, and brings together thousands of healthcare leaders.
As CEO, I am thrilled and excited to transform and advance healthcare by building a thriving and diverse ecosystem and unlocking the power of community, collaboration, content and convening that fulfills the dreams of entrepreneurs, fuels breakthroughs, drives diversity and inclusion, economic growth, and advances healthcare outcomes. Join our weekly Tuesday Talks, and our monthly main event, CureX, or apply for the soon to be open innovation challenge to leverage AI for good. Now, more than ever, integration across the continuum of healthcare is critical. We have the power to ensure that our people, products, and planet are healthy and thriving. Together, we can create a better world. Come join us.
Seema Kumar Chief Executive Officer Cure
|
|
| Seema Kumar Chief Executive Officer |
|
| About Seema Seema Kumar is the CEO of Cure Experience since 2022. With almost 20 years at Johnson & Johnson, she held senior leadership roles, including Global Head of Office of Innovation, Global Health, and Scientific Engagement. She led external affairs efforts and public education programs on COVID and vaccine literacy. Previously, she served as Chief of Staff at the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research and held leadership positions at the U.S. National Institutes of Allergy and Infectious Diseases, the National Institutes of Health, and Johns Hopkins School of Medicine. Kumar has an M.S. in Science Journalism and Communications from the University of Maryland.
|
| About Cure Cure is a 12-story innovation campus in the heart of New York City that features cutting-edge wet labs, premium event venues, and office space—plus tools, mentoring, and other assistance to physician-scientists, entrepreneurs, academics, and nonprofits working across the spectrum of healthcare and biomedicine. Cure’s mission is to foster and accelerate the development of therapies and cures, and to facilitate critical conversations about the future of healthcare and medicine. |
|
|
| "I look forward to working with the team to unlock the power of community, collaboration, content and convening that fulfills the dreams of entrepreneurs, fuels breakthroughs, drives diversity and inclusion, economic growth, and advances healthcare outcomes."
– Seema Kumar, Chief Executive Officer |
|
|
|
|
